Collagen Peptides

Collagen peptides occupy an unusual position in the supplement landscape: the marketing claims are aggressive, the influencer endorsements are everywhere, and the underlying evidence is — surprisingly — better than the typical skin-supplement category. Not great. Not life-changing. But better than nothing, and better than most of the things that share shelf space with it.

The mechanism matters because it determines whether the supplement should work at all. Dietary collagen — the kind you get from bone broth or chicken skin — is broken down by gut proteases into amino acids and dipeptides like any other protein. There is no special “collagen-to-collagen” pipeline. So why would taking it in supplement form do anything?

The answer appears to be that hydrolyzed collagen peptides include a specific class of di- and tripeptides — particularly Pro-Hyp (proline-hydroxyproline) and Gly-Pro-Hyp — that survive intact absorption across the small intestine. These peptides have been measured in circulation after oral collagen ingestion in humans (a pharmacokinetic finding that distinguishes collagen from most dietary proteins). Once in circulation, they reach skin and joint tissues, where in vitro studies show they stimulate fibroblasts to produce new collagen, elastin, and hyaluronic acid. The supplement is acting as a signaling molecule, not a building block.

The clinical evidence comes in three buckets:

Skin. The two Proksch 2014 trials are the most-cited — both used Verisol (a specific bioactive collagen peptide blend) at 2.5 g/day for 8 weeks in women aged 35-65. The first showed significant skin elasticity improvement; the second showed 20% reduction in eye wrinkle volume and increased dermal matrix synthesis on biopsy. Effects persisted 4 weeks after stopping. Multiple replications since have shown similar but smaller effects. The catch: most trials are industry-funded by Gelita (Verisol manufacturer), and independent replications tend to find smaller effect sizes.

Joints. Clark 2008 (24 weeks, 147 athletes) is the foundational joint trial — 10 g/day collagen hydrolysate reduced joint pain during activity vs placebo. Multiple smaller trials since show similar modest effects, particularly in active populations with exercise-related joint discomfort. Evidence is weaker for established osteoarthritis (mixed results), and glucosamine-chondroitin has more trial data for that specific use case.

Muscle. The Zdzieblik 2015 trial is the most rigorous — 53 sarcopenic men (mean age 72) on a 12-week resistance training program received either 15 g/day collagen peptides or silica placebo. The treatment group gained more fat-free mass, more leg strength, and lost more fat mass. The mechanism here is probably the leucine and proline content acting as a protein source rather than the peptide signaling effect, but the trial result is real.

What collagen peptides won’t do: replace whey protein for muscle building in younger athletes (collagen has a poor essential amino acid profile and lacks tryptophan entirely), reverse advanced wrinkles or sagging (effect sizes are modest — measurable but not dramatic), or rebuild damaged cartilage (no good evidence for structural joint changes, only symptomatic improvement).

Practical guidance: 10-20 g/day of unflavored hydrolyzed collagen powder, mixed into coffee, smoothies, or water. Pair with vitamin C (or take with citrus). Effects take 8-12 weeks to appear — short trials don’t work. Brand quality varies; Vital Proteins, Sports Research, and Great Lakes are commonly recommended. Branded peptides (Verisol for skin, Fortigel for joints, Tendoforte for tendons) have the most direct trial evidence but cost more. Generic grass-fed bovine collagen peptides are reasonable for general use.

Don’t expect dramatic results. Do expect modest, measurable improvements over a 3-month course in skin elasticity, joint comfort, and (if combined with resistance training) muscle mass in older adults.